• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, September 18, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

The need to understand what works in social prescribing

Bioengineer by Bioengineer
July 18, 2017
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: University of Plymouth

Social prescribing has the potential to address many of the factors that perpetuate illness, decrease quality of life and add to health care costs – such as social isolation, inactivity and smoking. It has expanded the options available to GPs who have patients requiring financial, housing and other social advice alongside their medical care.

In a piece published today, 18th July 2017, in BMJ Opinion, a health service research expert from the University of Plymouth warns that, in order for social prescribing to reach its full potential and make a true difference to patients, more needs to be done to understand what works, for whom, and in what circumstances.

Dr Kerryn Husk is a National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care South West Peninsula (NIHR PenCLAHRC) health service research fellow in the Clinical Trials and Health Research Team at Plymouth University Peninsula Schools of Medicine and Dentistry.

Dr Husk highlights the potential of social prescribing and draws attention to instances where it has not achieved what it set out to do. An example is the exercise referral scheme (ERS), described by Dr Husk as "all but a panacea a decade ago". He states that, because ERS were adopted across the UK before its effectiveness was properly assessed, the outcome was that for a substantial number of patients ERS offered benefit that was not optimised.

"This sits at the heart of what needs to be done with social prescribing," said Dr Husk. "Greater attention needs to be paid to how it can address individualisation and be responsiveness to the needs of different groups of patients and care providers – one size does not necessarily fit all."

More research into the delivery and effectiveness of social prescribing could not be more timely – there is a policy push in the UK to see social prescribing as part of the 'new models of care' which aim to contribute to health creation and reduce pressure on the NHS through better healthcare utilisation.

Said Dr Husk: "We must seize the opportunity we have now to develop a programme of research alongside the implementation of social prescribing …. so as to understand which patients can accrue benefits (improved social functioning, disease prevention, fewer admissions) and from which interventions."

He also suggests that there needs to be a deepened understanding of each patient's "nuanced interactions" with the professionals and advisors they encounter on their social prescription journey.

He added: "If we want to harness the great work now being undertaken in community and primary care settings up and down the UK, we need to understand what works in social prescribing, for whom, and in what circumstances."

###

Read Dr Husk's piece – http://blogs.bmj.com/bmj/2017/07/18/social-prescribing-offers-huge-potential-but-requires-a-nuanced-evidence-base/

Media Contact

Andrew Gould
andrew.gould@plymouth.ac.uk
@PlymUni

http://www.plymouth.ac.uk

Share12Tweet7Share2ShareShareShare1

Related Posts

Tirzepatide Enhances Blood Sugar Regulation in Adolescents with Type 2 Diabetes Unresponsive to Current Treatments (SURPASS-PEDS Trial)

September 18, 2025

Texas A&M Researchers Develop Innovative Cryopreservation Technique to Stop Organ Cracking

September 18, 2025

Optimizing Geriatric Care: Staff Insights on Patient Mobilization

September 18, 2025

Researchers Pinpoint Potential Therapeutic Targets in Pediatric Germ Cell Tumors

September 18, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    155 shares
    Share 62 Tweet 39
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    117 shares
    Share 47 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    67 shares
    Share 27 Tweet 17
  • Tailored Gene-Editing Technology Emerges as a Promising Treatment for Fatal Pediatric Diseases

    49 shares
    Share 20 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Tirzepatide Enhances Blood Sugar Regulation in Adolescents with Type 2 Diabetes Unresponsive to Current Treatments (SURPASS-PEDS Trial)

Emerging Research Links Microplastics to Potential Risks for Bone Health

Early Universe Galaxies Unveil Hidden Dark Matter Maps

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.